A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MenACWY-TT

Search Conditions:
Search Keyword : MenACWY-TT
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: MenACWY-TT
Appearance Frequency: 22 time(s)
Long forms: 9

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
meningococcal serogroups A, C, W, Y tetanus toxoid conjugate vaccine
(7 times)
Allergy and Immunology
(6 times)
SAEs (4 times)
Men-PS (2 times)
NOCIs (2 times)
2010 A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children.
meningococcal ACWY-tetanus toxoid conjugate vaccine
(6 times)
Allergy and Immunology
(4 times)
SAEs (3 times)
AEs (2 times)
GMTs (1 time)
2012 Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers.
MenACWY vaccine conjugated to tetanus toxoid
(3 times)
Communicable Diseases
(1 time)
MenACWY (2 times)
IMD (1 time)
MenW (1 time)
2017 Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
MenACWY conjugated to tetanus toxoid as a carrier protein
(1 time)
Allergy and Immunology
(1 time)
MenACWY (1 time)
MenC (1 time)
2020 Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studies.
meningococcal A, C, W, Y-tetanus toxoid conjugate
(1 time)
Communicable Diseases
(1 time)
GMTs (1 time)
2020 A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years.
meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate
(1 time)
Allergy and Immunology
(1 time)
--- 2009 Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years.
meningococcal A, C, W-135, and Y tetanus toxoid conjugate vaccine
(1 time)
Communicable Diseases
(1 time)
EU (1 time)
2013 Persistence of antibodies for 42 months following vaccination of adolescents with a meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine (MenACWY-TT).
meningococcal ACWY-polysaccharide-specific tetanus toxoid-conjugated
(1 time)
--- 2020 Different Long-Term Duration of Seroprotection against Neisseria meningitidis in Adolescents and Middle-Aged Adults after a Single Meningococcal ACWY Conjugate Vaccination in The Netherlands.
meningococcal serogroups ACWY tetanus toxoid
(1 time)
Communicable Diseases
(1 time)
--- 2015 Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults: An Open, Randomized Trial.